{
  "id": 3624229,
  "title": "Pancreatic cancer drug Daraxonrasib gets approval from FDA: All you need to know",
  "url": "https://urgent.news/2026/08/27/pancreatic-cancer-drug-daraxonrasib-gets-approval-from-fda-all-you",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-27T00:08:28.000Z",
  "source": {
    "name": "Hindustan Times - World News",
    "slug": "hindustan-times-world-news",
    "url": "https://www.hindustantimes.com/world-news/us-news/pancreatic-cancer-drug-daraxonrasib-gets-approval-from-fda-all-you-need-to-know-101787788402798.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "The FDA has approved a new drug, daraxonrasib, for advanced pancreatic cancer, marking a significant breakthrough in treating one of the deadliest forms of cancer. The pill, sold under the brand name Rasonque by Revolution Medicines, targets mutated proteins that fuel tumor growth in over 90% of pancreatic cancer cases. In a study, patients taking the drug showed nearly double the survival time compared to those receiving chemotherapy, with fewer severe side effects. The drug, which costs about $39,800 for a one-month supply, is particularly noteworthy as pancreatic cancer has been notoriously difficult to treat due to its late detection and the \"undruggable\" nature of its underlying mutations. This approval not only offers a more effective treatment option for patients but also paves the way for other drugs targeting similar genetic mutations in various cancers.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "The Conversation",
        "title": "FDA approves breakthrough pancreatic cancer drug – an oncologist explains how daraxonrasib nearly doubles survival",
        "url": "https://urgent.news/2026/08/26/fda-approves-breakthrough-pancreatic-cancer-drug-an-oncologist",
        "published": "2026-08-26T19:57:46.000Z"
      },
      {
        "outlet": "The Indian Express",
        "title": "Pancreatic cancer’s once daily pill gets US FDA nod: What it means for therapy and India?",
        "url": "https://urgent.news/2026/08/27/pancreatic-cancers-once-daily-pill-gets-us-fda-nod-what-it-means-for",
        "published": "2026-08-27T02:28:21.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}